SPR Endorses an ACR Statement

The Board of Directors of the Society for Pediatric Radiology endorses the ACR Statement on Use of Iodinated Contrast Material for Medical Imaging in Young Children and Need for Thyroid Monitoring¹, a response to the FDA’s recommendation for thyroid monitoring in newborns and children through three years of age who receive injections of iodine-containing contrast media for medical imaging².  The Society for Pediatric Radiology supports the evidence-based safe imaging of children and advocates for further high-quality research on this topic.

References:

1. https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Use-of-Iodinated-Contrast-Material-for-Medical-Imaging-in-Young-Children
2. https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-thyroid-monitoring-babies-and-young-children-who-receive-injections-iodine-containing